CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 4 Planned sale CEO sold 30,078 shares at $24.58 ($739,317)
- 4 Planned sale Chief Medical Officer sold 6,700 shares at $24.58 ($164,686)
- 4 Planned sale SVP, Finance and Treasurer sold 3,242 shares at $24.58 ($79,688)
- 4 Planned sale Chief Legal Officer sold 5,956 shares at $24.58 ($146,398)
- 4 Planned sale President sold 11,810 shares at $24.58 ($290,290)
- 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
- 4 Grant or award SVP, Finance and Treasurer acquired 20,000 shares (grant or award)
Page 2 of 26 · 514 filings